Wellness Hour | Home No More: A New Shot At Health

Aspen Pharmacare has just received approval from SAHPRA for Mounjaro — a drug originally designed for diabetes, now cleared for chronic weight management. It’s being hailed as a medical breakthrough, but beneath the
celebration lies a bigger conversation. South Africa is one of the most overweight nations in Africa, with rising diabetes and heart disease rates putting immense pressure on an already strained healthcare system. If Mounjaro promises to manage weight and control blood sugar, could it be a game changer — or just another expensive fix in a country where lifestyle related illnesses are skyrocketing and public health access remains unequal?